Aurskog logo horisontal.png
AURG44 PRO - Nøkkelinformasjon ved innfrielse av deler av obligasjonslån
March 01, 2024 08:16 ET | Aurskog Sparebank
Utsteder: Aurskog SparebankISIN for obligasjonslånet: NO0010852817Dato for innfrielse: 05.03.2024Beløp som innfris: MNOK 78Utestående beløp etter innfrielse: MNOK 65Innløsingskurs: 99,457 ...
Aurskog logo horisontal.png
Aurskog Sparebank: Nedkvittering og utvidelse av obligasjonslån
March 01, 2024 08:15 ET | Aurskog Sparebank
Aurskog Sparebank har i dag utført følgende nedkvittering og utvidelse i obligasjonslån: Fastrente senior obligasjonslån: AURG44 PRO ISIN NO0010852817Nedkvittering MNOK 78. Ny beholdning er MNOK...
alumis logo.png
Alumis Presents Preclinical Data for Allosteric TYK2 Inhibitor A-005 at ACTRIMS
March 01, 2024 08:00 ET | Alumis Inc
– A-005 is a potential first-in-class, brain penetrant TYK2 inhibitor for the treatment of neuroinflammatory and neurodegenerative diseases – – Data support planned Phase 1 clinical trial on track to...
Immuneering-logo (1).png
Immuneering Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
March 01, 2024 08:00 ET | Immuneering Corporation
- Topline data from the Phase 1 portion of Phase 1/2a trial of IMM-1-104 expected in March 2024 - - Dosing of first patient in the expanded Phase 2a portion of Phase 1/2a trial of IMM-1-104...
KODAK LOGO.jpg
Company Statement
March 01, 2024 08:00 ET | Eastman Kodak
ROCHESTER, N.Y., March 01, 2024 (GLOBE NEWSWIRE) -- In response to public media reports regarding Eastman Kodak Company’s U.S. pension fund, Kodak confirms that the Kodak Retirement Income Plan...
Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
March 01, 2024 08:00 ET | Blue World Acquisition Corp
New York, March 01, 2024 (GLOBE NEWSWIRE) --  Blue World Acquisition Corporation (the “Company”) (NASDAQ: BWAQ) today announced that, in order to extend the date by which the Company mush complete...
market-digits.jpg
Europe Foamed Plastic Market projected to reach USD 16.40 Billion by 2030, growing at a CAGR of 2.61% during the forecast period of 2023-2030 - says MarketDigits in its latest study Richmond, March 01, 2024 (GLOBE NEWSWIRE) -- According to a research report "Europe Foamed Plastic Market”, by Type (Polyurethane (PU) Foams, Polystyrene (PS) Foams [Expanded Polystyrene (EPS),...
vTv Graps Logo.png
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
March 01, 2024 08:00 ET | vTv Therapeutics Inc.
HIGH POINT, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an...
Aemetis Logo.png
Aemetis to Review Fourth Quarter and Year End 2023 Financial Results on March 7, 2024
March 01, 2024 08:00 ET | Aemetis, Inc.
CUPERTINO, CA, March 01, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its fourth quarter...
Fate Therapeutics.jpg
Fate Therapeutics to Present at Upcoming March Investor Conferences
March 01, 2024 08:00 ET | Fate Therapeutics, Inc.
SAN DIEGO, March 01, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a...